Symbols

SEM

Select Medical·NYSE

--(--)

SEM fundamentals

SEM Q4 2025 Earnings

Select Medical (SEM) released its earnings on Feb 19, 2026: revenue was 1.40B (YoY +6.41%), beat estimates; EPS was 0.16 (YoY -11.11%), missed estimates.

Revenue / YoY

1.40B

+6.41%

EPS / YoY

0.16

-11.11%

Report date

Feb 19, 2026

SEM Earnings Call Summary for Q4,2025

Expansion momentum: Added 212 beds in 2025, with 399 beds expected by end-2027, driving inpatient rehab revenue growth.
Outpatient recovery: 2026 outlook for outpatient EBITDA improvement, supported by 2% Medicare rate increase.
Financial discipline: 2026 guidance reflects cautious optimism, with $520-540M EBITDA target.
Strategic focus: Prioritizing inpatient rehab growth over share buybacks during take-private review.
Risk factors: Higher health insurance costs ($15M Q4 impact) and competitive pressures in outpatient.

Earnings

EPS

Revenue

Revenue & Expenses

SEM has released its 2025 Q4 earnings report, with revenue of 1.40B, reflecting a YoY change of 6.41%, and net profit of 37.74M, showing a YoY change of 904.85%. The Sankey diagram below clearly presents SEM's revenue sources and cost distribution.

Key Indicators

Select Medical (SEM) key financial stats and ratios, covering profitability, financial health, and leverage.

Income Statement

Select Medical (SEM)'s revenue and profit trends over recent years, visualized with a waterfall chart to showcase the revenue-to-profit funnel.

Trend

Breakdown

Balance Sheet

Select Medical (SEM)'s asset and liability trends over recent years, visualized with a waterfall chart to illustrate changes in its asset-liability structure.

Trend

Breakdown

Cash Flow

Select Medical (SEM)'s cash flow trends over recent years, visualized with a waterfall chart to illustrate changes in its operating, investing, and financing cash flows.

Trend

Breakdown